H.R. 1143 · 119th Congress
Medicare IVIG Access Enhancement Act of 2025
In committee
See what this could mean for your district
Save your district in Account to view district-specific context for this bill.
Bill details
Introduced: 2/7/2025
Current status: In committee
Introduced by: Adrian Smith (R · NE-03)
Bill ID: 119hr1143
Latest official action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill overview
A neutral overview based on official congressional sources.
Introduced in House
Medicare IVIG Access Enhancement Act of 2025 This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)
Source: BILLSUM · Summary date: 2/7/2025
Related votes
Roll calls that reference this bill in official data.
0 roll calls
No related roll calls found yet for this bill.
Primary sources
Official links to verify details. No interpretation.
About this data
Non-partisan by design
OurCongress presents public records without political endorsement, interpretation, or advocacy.
Official sources
Data is sourced from official government records, including Congress.gov, GovInfo, the Clerk of the House, and the U.S. Senate.
AI-generated text
Some explanatory sections may be generated from official summaries and metadata to improve readability. They are not official government language and should be verified against primary sources.